Why the study?
Is it worthwhile and possible to safely and effectively vaccinate human beings against acute anterior poliomyelitis?
Is it worthwhile and possible to safely and effectively vaccinate human beings against acute anterior poliomyelitis?
This paper discusses the theoretical and practical considerations for developing and applying a vaccine against acute anterior poliomyelitis.
Discussion of polio vaccine considerations remains hypothesis-generating; leaves open empirical validation of safety and efficacy before clinical consideration.
Is it worth while to attempt vaccination against acute anterior poliomyelitis in view of the low attack rate of the disease? If so, what are the prospects of success attending such efforts since the disease is evidently caused by a virus probably multiplying on or in the susceptible anterior horn cells of the spinal cord and causing the pronounced signs of disease only when coming in contact with such cells? Is it likely that anti-body produced in human beings by vaccine of spinal cords of monkeys infected with remote passage virus will protect against the disease? If this appears possible, how should the vaccine be prepared? And if it is found possible to vaccinate human beings safely and effectively against poliomyelitis with such vaccine, how should the method be applied as a practical procedure? These and additional problems of related interest are briefly discussed herewith as the basis of my
No takes yet. Share an insight, caveat, or question.
John A. Kolmer (1935) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: